Therapeutic flag Cosmetic cross-reference

Ciclopirox Olamine

CAS 41621-49-2

Ciclopirox Olamine (CAS 41621-49-2) is a Phase 3 pharmaceutical compound with 6 bioactivity targets and 212 adverse event associations.

SOURCE NLM DailyMed

Label records

0

SOURCE EMBL-EBI ChEMBL

Bioactivity

6

SOURCE DrugCentral

Adverse signals

212

SOURCE IUPHAR/BPS

PubMed IDs

0

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name

Ciclopirox Olamine

CAS Number

41621-49-2

UNII

50MD4SB4AP

InChIKey

MBRHNTMUYWQHMR-UHFFFAOYSA-N

ChEMBL ID

CHEMBL242580

Molecule Type

Small molecule

Source Match

EMBL-EBI ChEMBL (INCHIKEY)

therapeutic flag

SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 3

Late-stage clinical development phase from the compound identifier source.

ChEMBL CHEMBL242580 | Small molecule

SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →

SOURCE EMBL-EBI ChEMBL 6 bioactivity rows

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

Target	Activity	Value	Assays	Organism
-	GI50	9268.211132075472 nM	53	-
-	Potency	14259.607575757575 nM	50	-
-	MIC	387.75612244897957 ug.mL-1	49	-
-	IC50	14415.114242424243 nM	33	-
-	AC50	14663.904285714283 nM	7	-
-	EC50	630 nM	1	-

SOURCE NLM RxNorm 2 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

Name	RxCUI	Type	Source
CICLOPIROX OLAMINE	52172	SU	MTHSPL
ciclopirox olamine	52172	PIN	RXNORM

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Ciclopirox Olamine used for in pharmaceutical contexts?

Ciclopirox Olamine (CAS 41621-49-2) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Ciclopirox Olamine?

Ciclopirox Olamine has 212 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Abnormal behaviour, Allodynia, Asthenia, Balance disorder, Breast pain. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Ciclopirox Olamine also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Ciclopirox Olamine with EU status "restricted".

What clinical phase is Ciclopirox Olamine in?

Ciclopirox Olamine is rendered with ChEMBL max phase 3.